Main Content

CRS response to CADTH’s therapeutic review of VEGF drugs

Canadian Retina Society (CRS) final response to CADTH’s Draft Therapeutic Review Recommendation Report entitled, “Anti-vascular endothelial growth factor (VEGF) drugs for the treatment of retinal conditions”(December 2015)

Read response